VUNO Secures FDA 510(k) Clearance for VUNO Med®-DeepBrain®
SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- VUNO Inc., South Korean
medical AI company has received 510(k) clearance from the Food and Drug
Administration (FDA) for its AI-powered brain quantification device, VUNO
Med®-DeepBrain®.
VUNO's First AI-based Prospective Study Results Published in Critical Care
SEOUL, South Korea, Sept. 18, 2023 /PRNewswire/ -- VUNO Inc., South Korean medical AI company announced that its AI-based cardiac arrest risk management system, VUNO Med®-DeepCARS™, has proven its clinical validity for the first time through a prospective study utilizing Real World Data(RWD). <...
VUNO Showcases their AI Solutions and Research Results at RSNA 2022
SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ -- VUNO Inc., a leading South Korean artificial intelligence (AI) developer, announced that it will participate in the Radiological Society ofNorth America 2022 (RSNA 2022). This year, VUNO will focus on highlighting how their breakthrough AI technol...
VUNO Boasts of its AI Solutions and Research Results at RSNA 2021
SEOUL, South Korea, Nov. 28, 2021 /PRNewswire/ -- South Korean artificial intelligence (AI) developer VUNO Inc. announced that it will join the Radiological Society ofNorth America 2021 (RSNA 2021), one of the biggest annual events, featuring a series of industry symposia in radiology. This year,...
VUNO Signs Another Deal with Samsung Electronics to Incorporate AI-assisted Solutions into Samsung's Premium Ceiling Type Digital Radiography System
SEOUL, South Korea, Oct. 5, 2021 /PRNewswire/ -- South Korean artificial intelligence (AI) developer, VUNO Inc., announced today that the company closed a deal with global medical device manufacturer, Samsung Electronics Co., Ltd., to embed VUNO's artificial intelligence-driven chest X-ray diagno...
MFDS Greenlights VUNO Med®-DeepCARS™, AI Medical Device for Cardiac Arrest Prediction
SEOUL, South Korea, Aug. 24, 2021 /PRNewswire/ -- South Korean artificial intelligence (AI) developer, VUNO Inc. announced today that it has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) for its VUNO Med®–DeepCARS™, an AI medical device for cardiac arrest predictio...
